Index S&P 500
P/E 25.25
EPS (ttm) 3.28
Insider Own 0.08%
Shs Outstand 1.28B
Perf Week -1.68%
Market Cap 106.08B
Forward P/E 14.16
EPS next Y 5.84
Insider Trans 0.00%
Shs Float 1.28B
Perf Month -6.31%
Income 4.29B
PEG 4.39
EPS next Q 1.36
Inst Own 84.64%
Short Float 0.78%
Perf Quarter -8.08%
Sales 33.00B
P/S 3.22
EPS this Y 4.82%
Inst Trans -0.88%
Short Ratio 1.64
Perf Half Y 1.31%
Book/sh 37.81
P/B 2.19
EPS next Y 7.18%
ROA 4.76%
Short Interest 10.01M
Perf Year 3.31%
Cash/sh 6.23
P/C 13.28
EPS next 5Y 5.75%
ROE 8.58%
52W Range 75.96 - 92.68
Perf YTD 0.42%
Dividend Est. 2.71 (3.28%)
P/FCF 19.29
EPS past 5Y -4.12%
ROI 5.87%
52W High -10.74%
Beta 0.83
Dividend TTM 2.78 (3.36%)
Quick Ratio 1.39
Sales past 5Y 1.24%
Gross Margin 60.08%
52W Low 8.91%
ATR (14) 1.30
Dividend Ex-Date Dec 27, 2024
Current Ratio 1.84
EPS Y/Y TTM 6.56%
Oper. Margin 17.93%
RSI (14) 29.87
Volatility 1.15% 1.60%
Employees 95000
Debt/Eq 0.58
Sales Y/Y TTM 3.25%
Profit Margin 13.00%
Recom 2.32
Target Price 94.79
Option/Short Yes / Yes
LT Debt/Eq 0.51
EPS Q/Q 44.60%
Payout 99.87%
Rel Volume 0.90
Prev Close 82.92
Sales Surprise 1.55%
EPS Surprise 0.83%
Sales Q/Q 5.25%
Earnings Nov 19 BMO
Avg Volume 6.09M
Price 82.73
SMA20 -2.92%
SMA50 -5.78%
SMA200 -2.06%
Trades
Volume 5,479,907
Change -0.23%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-10-24 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$98 → $105
Aug-21-24 Reiterated
Oppenheimer
Perform
$92 → $94
Aug-15-24 Upgrade
UBS
Sell → Neutral
$76 → $90
Aug-14-24 Downgrade
Stifel
Buy → Hold
$100 → $85
May-30-24 Initiated
Goldman
Sell
$83
Jul-19-23 Initiated
Robert W. Baird
Neutral
$90
Jun-30-23 Initiated
CL King
Buy
$106
May-30-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$104
Apr-24-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$77 → $100
Mar-29-23 Downgrade
UBS
Buy → Sell
$127 → $79
Jan-09-23 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$102 → $89
Nov-23-22 Downgrade
Oppenheimer
Outperform → Perform
$106 → $85
Nov-23-22 Downgrade
Citigroup
Buy → Neutral
$108 → $85
Nov-16-22 Downgrade
Deutsche Bank
Buy → Hold
$85
Oct-18-22 Initiated
Barclays
Equal Weight
$90
Oct-13-22 Initiated
Mizuho
Buy
$100
Oct-12-22 Initiated
Jefferies
Hold
$87
Aug-24-22 Downgrade
Raymond James
Outperform → Mkt Perform
Jul-06-22 Initiated
Wolfe Research
Underperform
$85
Jun-01-22 Downgrade
Atlantic Equities
Overweight → Neutral
$125 → $105
Show Previous Ratings
Dec-12-24 03:08PM
Dec-07-24 09:17AM
Dec-05-24 04:30PM
11:25AM
Dec-04-24 09:15AM
08:45AM
Loading…
Dec-03-24 08:45AM
Nov-29-24 10:38AM
Nov-28-24 07:45AM
Nov-27-24 08:54AM
(Pharmaceutical Technology)
Nov-26-24 06:18AM
01:58AM
Nov-25-24 01:06AM
Nov-22-24 12:05PM
06:28AM
04:50AM
05:40PM
Loading…
Nov-21-24 05:40PM
09:40AM
07:00AM
05:17AM
Nov-20-24 03:14PM
11:04AM
09:45AM
08:45AM
08:30AM
07:24AM
02:03AM
Nov-19-24 06:22PM
04:04PM
(Investor's Business Daily)
03:15PM
12:13PM
11:27AM
Loading…
11:27AM
09:30AM
08:51AM
(Investor's Business Daily)
07:55AM
07:17AM
07:13AM
06:55AM
(Associated Press Finance)
06:45AM
Nov-18-24 04:42PM
10:00AM
06:48AM
Nov-15-24 05:45PM
Nov-14-24 11:43AM
09:15AM
Nov-12-24 04:12PM
Nov-08-24 05:45PM
Nov-07-24 06:35AM
Nov-05-24 02:33PM
05:38AM
Nov-04-24 07:13AM
05:17AM
Nov-02-24 11:55AM
Nov-01-24 05:45PM
05:22PM
Oct-31-24 07:00AM
06:00AM
Oct-29-24 06:24AM
Oct-28-24 05:50PM
02:15PM
Oct-25-24 06:14AM
06:00AM
Oct-24-24 04:33PM
07:57AM
Oct-23-24 01:06PM
Oct-22-24 05:50PM
Oct-21-24 12:38PM
Oct-16-24 11:32AM
Oct-15-24 04:40PM
07:58AM
Oct-14-24 07:37AM
Oct-11-24 05:50PM
11:47AM
Oct-10-24 05:38AM
Oct-09-24 03:10PM
07:50AM
Oct-07-24 05:42AM
Oct-04-24 05:50PM
01:33PM
10:13AM
06:45AM
Oct-02-24 04:11AM
Oct-01-24 10:00AM
Sep-30-24 04:52AM
Sep-27-24 07:00PM
09:40AM
Sep-26-24 05:50PM
11:23AM
04:12AM
Sep-25-24 08:34AM
08:23AM
08:00AM
07:53AM
Sep-20-24 11:54AM
Sep-19-24 11:30AM
08:02AM
07:13AM
Sep-18-24 06:32AM
04:52AM
Sep-14-24 05:36PM
10:05AM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PARKHILL KAREN L Former Director Oct 31 '24 Proposed Sale 89.73 30,000 2,691,794 Oct 31 03:21 PM PARKHILL KAREN L Former Director Oct 30 '24 Proposed Sale 90.58 15,000 1,358,740 Oct 30 04:11 PM PARKHILL KAREN L Former BOD Oct 29 '24 Proposed Sale 91.16 15,000 1,367,348 Oct 29 03:26 PM PARKHILL KAREN L Former Director Oct 24 '24 Proposed Sale 92.49 22,712 2,100,633 Oct 24 04:01 PM PARKHILL KAREN L Former Director Oct 23 '24 Proposed Sale 91.76 23,848 2,188,205 Oct 23 04:30 PM PARKHILL KAREN L Former BOD Oct 18 '24 Proposed Sale 91.74 48,825 4,479,310 Oct 18 04:24 PM PARKHILL KAREN L Former BOD Oct 17 '24 Proposed Sale 89.87 55,179 4,958,718 Oct 17 03:35 PM PARKHILL KAREN L Former Officer Aug 26 '24 Proposed Sale 90.00 2,668 240,120 Aug 26 02:11 PM Wall Brett A. EVP & Pres Neuroscience Aug 02 '24 Option Exercise 0.00 5,311 0 49,169 Aug 06 06:16 PM Walter Matthew R. SVP, Chief HR Officer Aug 02 '24 Option Exercise 0.00 684 0 25,889 Aug 06 06:15 PM Smith Gregory L EVP Global Ops & Supply Chain Aug 02 '24 Option Exercise 0.00 3,490 0 64,757 Aug 06 06:14 PM Salmon Sean EVP & President Cardiovascular Aug 02 '24 Option Exercise 0.00 5,462 0 68,546 Aug 06 06:14 PM PARKHILL KAREN L EVP & Chief Financial Officer Aug 02 '24 Option Exercise 0.00 7,132 0 53,459 Aug 06 06:13 PM Martha Geoffrey Chairman and CEO Aug 02 '24 Option Exercise 0.00 18,966 0 203,086 Aug 06 06:13 PM Marinaro Michael EVP & President, Surgical OU Aug 02 '24 Option Exercise 0.00 1,670 0 43,801 Aug 06 06:12 PM Kirk Jennifer M Chief Accounting Officer Aug 02 '24 Option Exercise 0.00 1,138 0 28,980 Aug 06 06:12 PM Fong Ivan K EVP GENERAL COUNSEL & SECR Aug 02 '24 Option Exercise 0.00 14,514 0 63,750 Aug 06 06:11 PM Walter Matthew R. SVP, Chief HR Officer Jul 18 '24 Option Exercise 62.76 492 30,878 17,580 Jul 19 04:40 PM Martha Geoffrey Chairman and CEO Jun 07 '24 Option Exercise 62.76 19,113 1,199,532 162,461 Jun 11 06:53 PM Martha Geoffrey Chairman and CEO Jun 07 '24 Sale 83.77 19,113 1,601,001 143,348 Jun 11 06:53 PM Marinaro Michael EVP & President, Surgical OU Apr 08 '24 Sale 83.14 854 71,002 27,925 Apr 09 04:08 PM Salmon Sean EVP & President Cardiovascular Feb 21 '24 Option Exercise 69.07 30,695 2,120,121 78,984 Feb 23 05:18 PM Salmon Sean EVP & President Cardiovascular Feb 21 '24 Sale 85.13 30,695 2,613,055 48,289 Feb 23 05:18 PM Wall Brett A. EVP & Pres Neuroscience Dec 19 '23 Sale 82.17 4,997 410,603 28,910 Dec 20 11:41 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite